ETFIQData as of Nov 18, 2026. · etfiq.com/funds/fhlcDownload PDF

FHLC Fact Sheet: Fidelity MSCI Health Care Index ETF

Share
$86.45
close, Nov 18, 2026

Over the year to Nov 18, 2026, FHLC returned +19.8% in total and charged 0.08% a year.

1-year total return
+19.8%
VHT +19.7% to Nov 18, 2026
Expense ratio
0.08%
a year
Net assets
$4.0bn
on Oct 31, 2026
Net flow, 12 months to Jul 31, 2026
+$288m
monthly N-PORT basis to Jul 31, 2026

Growth of $10,000, 1 year

FHLC $11,981 +19.8% · VHT $11,967 +19.7% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.

Returns

WindowTotal return
1 month+2.6%
3 months+1.8%
Year to date+17.6%
1 year+19.8%
3 years+50.1%
5 years+40.7%

Total return, distributions reinvested, each window to Nov 18, 2026.

Ten largest positions

HoldingWeight
Eli Lilly & Co13.35%
Johnson & Johnson8.93%
AbbVie Inc6.42%
UnitedHealth Group Inc5.44%
Merck & Co Inc4.66%
Thermo Fisher Scientific Inc3.09%
Amgen Inc3.00%
Abbott Laboratories2.66%
Gilead Sciences Inc2.34%
Pfizer Inc2.06%

FHLC top ten by weight, 51.9% of the fund, of its 334 equity positions, from the holdings filed for Jul 31, 2026.

Facts

Equity fund · Tracks the MSCI USA IMI Health Care 25/50 Index · First traded Oct 24, 2013 · Benchmark MSCI USA IMI Health Care 25/50 Index, measured by VHT, which tracks the same index

Source: ETFIQ, from issuer disclosures, SEC filings and exchange prices. Returns from daily closes, distributions reinvested; each number is dated beside it, and every one is on the fund’s page.Cite as: ETFIQ, FHLC Fact Sheet: Fidelity MSCI Health Care Index ETF. Data as of Nov 18, 2026. https://etfiq.com/funds/fhlc/fact-sheet/ETFIQ is an independent publisher. Not an issuer, broker or adviser. No recommendations. Printed from etfiq.com/funds/fhlc.